Effect of vardenafil on cerebral vasospasm following experimental subarachnoid hemorrhage in rats
Authors:
- Sanser GulSGSanser Gul
- Burak BahadirBBBurak Bahadir
- Volkan HanciVHVolkan Hanci
- Sibel BektasSBSibel Bektas
- Murat CanMCMurat Can
- Murat KalayciMKMurat Kalayci
- Serefden AcikgozSASerefden Acikgoz
- Bektaş AcikgozBABektaş Acikgoz
- 1 August 2010
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 17 (8) , 1038-1041
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Type 5 Phosphodiesterase Inhibitors in the Treatment of Erectile Dysfunction and Cardiovascular DiseaseCardiology in Review, 2007
- Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthaseBritish Journal of Pharmacology, 2007
- Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic strokeBrain Research, 2007
- 2-methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in ratsExperimental Neurology, 2006
- Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial KATP channels in rabbitsJournal of Molecular and Cellular Cardiology, 2006
- Management of cerebral vasospasmNeurosurgical Review, 2006
- Effect of vardenafil, an inhibitor of phosphodiesterase‐5, on portal haemodynamics in normal and cirrhotic liver – results of a pilot studyAlimentary Pharmacology & Therapeutics, 2005
- Phosphodiesterase 5 Mechanisms and Therapeutic ApplicationsThe American Journal of Cardiology, 2005
- Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failureThe FASEB Journal, 2001
- Cortical Blood Flow and Cerebral Perfusion Pressure in a New Noncraniotomy Model of Subarachnoid Hemorrhage in the RatStroke, 1995